Published in J Vasc Surg on June 01, 2007
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care (2011) 2.23
Thrombospondin-1: a physiological regulator of nitric oxide signaling. Cell Mol Life Sci (2008) 1.23
Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling. Curr Drug Targets (2008) 0.88
Critical limb ischemia: reporting outcomes and quality. Methodist Debakey Cardiovasc J (2013) 0.75
Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation (2005) 2.67
The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines. J Vasc Surg (2009) 2.51
SVS practice guidelines for the care of patients with an abdominal aortic aneurysm: executive summary. J Vasc Surg (2009) 2.16
National trends in the use and outcomes of hepatic resection. J Am Coll Surg (2004) 1.92
Surgeon volume as an indicator of outcomes after carotid endarterectomy: an effect independent of specialty practice and hospital volume. J Am Coll Surg (2002) 1.91
Importance of refractory pain and hypertension in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation (2010) 1.84
Osteomyelitis of the foot and toe in adults is a surgical disease: conservative management worsens lower extremity salvage. Ann Surg (2005) 1.76
Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg (2003) 1.74
Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg (2003) 1.74
Differential regulation of aortic growth in male and female rodents is associated with AAA development. J Surg Res (2008) 1.72
Role and results of surgery in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation (2006) 1.66
Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg (2002) 1.64
Surgical treatment of intact thoracoabdominal aortic aneurysms in the United States: hospital and surgeon volume-related outcomes. J Vasc Surg (2003) 1.63
Hospital teaching status and outcomes of complex surgical procedures in the United States. Arch Surg (2004) 1.59
The impact of provider volume on mortality after intracranial tumor resection. Neurosurgery (2003) 1.59
Endovascular aortic aneurysm repair with carbon dioxide-guided angiography in patients with renal insufficiency. J Vasc Surg (2012) 1.53
Gender differences in experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol (2004) 1.51
Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model. Arterioscler Thromb Vasc Biol (2004) 1.49
Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg (2007) 1.47
Pediatric renovascular hypertension: 132 primary and 30 secondary operations in 97 children. J Vasc Surg (2006) 1.47
Changes in the utilization of spinal fusion in the United States. Neurosurgery (2006) 1.46
Outcomes after cerebral aneurysm clip occlusion in the United States: the need for evidence-based hospital referral. J Neurosurg (2003) 1.46
L-selectin-mediated neutrophil recruitment in experimental rodent aneurysm formation. Circulation (2005) 1.44
Variation in postoperative complication rates after high-risk surgery in the United States. Surgery (2003) 1.42
Impaired vasoreactivity despite an increase in plasma nitrite in patients with abdominal aortic aneurysms. J Vasc Surg (2002) 1.39
Tissue loss, early primary graft occlusion, female gender, and a prohibitive failure rate of secondary infrainguinal arterial reconstruction. J Vasc Surg (2002) 1.39
Variation in death rate after abdominal aortic aneurysmectomy in the United States: impact of hospital volume, gender, and age. Ann Surg (2002) 1.37
Targeted deletion of CCR2 impairs deep vein thombosis resolution in a mouse model. J Immunol (2006) 1.30
Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. J Vasc Surg (2005) 1.30
A population-based analysis of endovascular versus open thoracic aortic aneurysm repair. J Vasc Surg (2009) 1.27
Surgeon specialty and provider volumes are related to outcome of intact abdominal aortic aneurysm repair in the United States. J Vasc Surg (2003) 1.27
Hospital volume and surgical outcomes for elderly patients with colorectal cancer in the United States. J Surg Res (2003) 1.26
Who performs endocrine operations in the United States? Surgery (2003) 1.25
Measuring surgical quality: what's the role of provider volume? World J Surg (2005) 1.24
The impact of adjusting for reliability on hospital quality rankings in vascular surgery. J Vasc Surg (2010) 1.23
Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol (2013) 1.23
Female gender attenuates cytokine and chemokine expression and leukocyte recruitment in experimental rodent abdominal aortic aneurysms. Ann N Y Acad Sci (2006) 1.22
National trends in outcomes for esophageal resection. Ann Thorac Surg (2005) 1.21
Payer status is related to differences in access and outcomes of abdominal aortic aneurysm repair in the United States. Surgery (2003) 1.17
A contemporary analysis of outcomes for operative repair of type A aortic dissection in the United States. Surgery (2007) 1.17
Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution. Arterioscler Thromb Vasc Biol (2010) 1.16
Hybrid debranching with endovascular repair for thoracoabdominal aneurysms: a comparison with open repair. Ann Thorac Surg (2010) 1.15
Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during Angiotensin II induced aneurysm formation. J Surg Res (2006) 1.15
Endovascular technology, hospital volume, and mortality with abdominal aortic aneurysm surgery. J Vasc Surg (2008) 1.14
Challenges and opportunities in abdominal aortic aneurysm research. J Vasc Surg (2007) 1.12
Explaining racial disparities in mortality after abdominal aortic aneurysm repair. J Vasc Surg (2009) 1.12
Neutropenia impairs venous thrombosis resolution in the rat. J Vasc Surg (2003) 1.12
Bone marrow-derived MCP1 required for experimental aortic aneurysm formation and smooth muscle phenotypic modulation. J Thorac Cardiovasc Surg (2011) 1.11
Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg (2004) 1.10
Transient exposure to elastase induces mouse aortic wall smooth muscle cell production of MCP-1 and RANTES during development of experimental aortic aneurysm. J Vasc Surg (2003) 1.10
A national and single institutional experience in the contemporary treatment of acute lower extremity ischemia. Ann Surg (2003) 1.10
Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularization. Thromb Haemost (2006) 1.07
Common celiacomesenteric trunk: aneurysmal and occlusive disease. J Vasc Surg (2004) 1.05
Trends in utilization of adrenalectomy in the United States: have indications changed? World J Surg (2004) 1.05
Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment. Circulation (2012) 1.04
Abdominal aortic coarctation: surgical treatment of 53 patients with a thoracoabdominal bypass, patch aortoplasty, or interposition aortoaortic graft. J Vasc Surg (2008) 1.04
Understanding the racial disparity in the receipt of endovascular abdominal aortic aneurysm repair. Arch Surg (2010) 1.03
Use of endovascular coil embolization and surgical clip occlusion for cerebral artery aneurysms. J Neurosurg (2007) 1.03
Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis. Thromb Haemost (2007) 1.03
Late outcomes of endovascular aortic repair for the infected thoracic aorta. Ann Thorac Surg (2009) 1.01
A comparison of open and endovascular descending thoracic aortic repair in patients older than 75 years of age. Ann Thorac Surg (2008) 1.01
A nonintrinsic regional basis for increased infrarenal aortic MMP-9 expression and activity. J Vasc Surg (2003) 1.00
Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism. Thromb Haemost (2010) 0.99
Early MT-1 MMP expression following elastase exposure is associated with increased cleaved MMP-2 activity in experimental rodent aortic aneurysms. Surgery (2004) 0.97
Decreased collagen and increased matrix metalloproteinase-13 in experimental abdominal aortic aneurysms in males compared with females. Surgery (2009) 0.97
Primary aortoenteric fistula and endovascular repair. Vasc Endovascular Surg (2009) 0.96
Staged hybrid approach using proximal thoracic endovascular aneurysm repair and distal open repair for the treatment of extensive thoracoabdominal aortic aneurysms. J Vasc Surg (2012) 0.95
Long-term results from a 12-year experience with endovascular therapy for thoracic aortic disease. Ann Thorac Surg (2006) 0.95
Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms. J Vasc Surg (2005) 0.95
Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution. J Surg Res (2007) 0.95
Do popular media and internet-based hospital quality ratings identify hospitals with better cardiovascular surgery outcomes? J Am Coll Surg (2010) 0.95
A contemporary comparison of aortofemoral bypass and aortoiliac stenting in the treatment of aortoiliac occlusive disease. Ann Vasc Surg (2010) 0.94
Long-term results of percutaneous management of malperfusion in acute type B aortic dissection: implications for thoracic aortic endovascular repair. J Thorac Cardiovasc Surg (2009) 0.94
Gender-dependent differential phosphorylation in the ERK signaling pathway is associated with increased MMP2 activity in rat aortic smooth muscle cells. J Surg Res (2009) 0.94
Albumin is a better predictor of outcomes than body mass index following coronary artery bypass grafting. Surgery (2011) 0.93
Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin. J Vasc Surg (2008) 0.93
Acute abdominal aortic dissection: insight from the International Registry of Acute Aortic Dissection (IRAD). J Vasc Surg (2007) 0.93
The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling. J Vasc Surg (2013) 0.92
Graft infection after endovascular abdominal aortic aneurysm repair. J Vasc Surg (2011) 0.91
A biologic basis for asymmetric growth in descending thoracic aortic aneurysms: a role for matrix metalloproteinase 9 and 2. J Vasc Surg (2006) 0.91
Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression. J Surg Res (2002) 0.91
Ultrasound measurement of aortic diameters in rodent models of aneurysm disease. J Surg Res (2003) 0.91
Transluminal hypogastric artery occlusion with an Amplatzer vascular plug during endovascular aortic aneurysm repair. J Vasc Surg (2008) 0.91
Gender differences in rat aortic smooth muscle cell matrix metalloproteinase-9. J Am Coll Surg (2005) 0.91
KLF4 regulates abdominal aortic aneurysm morphology and deletion attenuates aneurysm formation. Circulation (2013) 0.91
Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline. Ann Vasc Surg (2010) 0.91
Turbulence significantly increases pressure and fluid shear stress in an aortic aneurysm model under resting and exercise flow conditions. Ann Vasc Surg (2007) 0.91
Vascular graft infections. Infect Dis Clin North Am (2012) 0.90
Effect of increasing patient age on complication rates following intact abdominal aortic aneurysm repair in the United States. J Surg Res (2004) 0.89
A comparative analysis of open and endovascular repair for the ruptured descending thoracic aorta. J Vasc Surg (2009) 0.89
Iliorenal bypass: indications and outcomes following 41 reconstructions. Ann Vasc Surg (2007) 0.89
Have thoracic endografting outcomes improved since US Food and Drug Administration approval? Ann Thorac Surg (2011) 0.89
Epidemiology of surgically treated gastric cancer in the United States, 1988-2000. J Gastrointest Surg (2003) 0.89
The role of extracellular signal-related kinase during abdominal aortic aneurysm formation. J Am Coll Surg (2012) 0.88
Bilateral external carotid artery aneurysms. Vascular (2005) 0.88
Increased MMP-9 expression and activity by aortic smooth muscle cells after nitric oxide synthase inhibition is associated with increased nuclear factor-kappaB and activator protein-1 activity. J Surg Res (2004) 0.88
National variation in operative mortality rates for esophageal resection and the need for quality improvement. Arch Surg (2003) 0.88
Differential effect of 17-beta-estradiol on smooth muscle cell and aortic explant MMP2. J Surg Res (2008) 0.87